4-Methoxycyclohexanol

Catalog No. :
ACKLCV514
CAS No. :
18068-06-9
Molecular Formula :
C7H14O2
Molecular Weight :
130.19

IUPAC Name:4-methoxycyclohexan-1-ol

4-Methoxycyclohexanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$56.00Login to see priceIn stockIn stock
25g97%$195.00Login to see priceIn stockIn stock
100g97%$700.00Login to see priceIn stockIn stock
500g97%$3220.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methoxycyclohexanol
IUPAC Name4-methoxycyclohexan-1-ol
MDL No.MFCD00019333
Molecular FormulaC7H14O2
Molecular Weight130.19
SMILESOC1CCC(OC)CC1
InChI KeyPFTGXSGDFZZZFY-UHFFFAOYSA-N
Synonym4-Methoxycyclohexanol | 18068-06-9 | trans-4-Methoxycyclohexanol | 22188-03-0 | 4-methoxycyclohexan-1-ol | Cyclohexanol, 4-methoxy- | cis-4-Methoxycyclohexanol | 22188-02-9 | 4-Methoxycyclohexanol (cis,trans) | (1s,4s)-4-methoxycyclohexan-1-ol | (1R,4R)-4-METHOXYCYCLOHEXAN-1
CAS No.18068-06-9
PubChem CID140332

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKLCV514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQBZR370 route compound structure diagram
    ACQBZR370556-48-9 In Stock
  4. Then
  5. ACKLCV514 route product structure diagram
    ACKLCV51418068-06-9 In Stock
Inquiry

2. ACKLCV514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACKLCV514 route product structure diagram
    ACKLCV51418068-06-9 In Stock
Inquiry

Comments (0)